Naptumomab (Anti-TPBG), 1mg*25

Naptumomab (Anti-TPBG), 1mg*25

Figitumumab (Anti-IGF1R / CD221), 1mg*5

Figitumumab (Anti-IGF1R / CD221), 1mg*5

Figitumumab (Anti-IGF1R / CD221), 1mg

2.614,43 RON
SKU
SKM_A2942_1mg

Figitumumab (Anti-IGF1R / CD221) is a human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM. MW: 146.0 KD.

Mai multe informatii
Price 2.197,00 RON (preturile sunt fara TVA)
Description

Figitumumab (Anti-IGF1R / CD221) is a human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM. MW: 146.0 KD.